Loading data
PAVMNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 71 k USD | 3 m USD | 2.45 m USD | 377 k USD | 500 k USD |
| Cost of revenue | 218 k USD | 4.84 m USD | 6.42 m USD | 3.61 m USD | 585 k USD |
| Research and development expense | 4.49 m USD | 5.93 m USD | 14.28 m USD | 25.34 m USD | 19.85 m USD |
| Operating profit | -21.81 m USD | -44.49 m USD | -68.8 m USD | -91.09 m USD | -54.39 m USD |
| Profit before tax | -2.47 m USD | 28.43 m USD | -79.26 m USD | -103.24 m USD | -56.13 m USD |
| Income tax expense | 0 USD | 0 USD | — | — | — |
| Net income (reported basis) | -3.77 m USD | 31.97 m USD | -66.27 m USD | -89.26 m USD | -50.35 m USD |
| Net income attributable to common shareholders | -3.8 m USD | 31.97 m USD | -66.27 m USD | -89.26 m USD | -50.63 m USD |
| Basic earnings per share | -5.63 USD/share | 99.15 USD/share | -9.16 USD/share | -15.03 USD/share | -0.65 USD/share |
| Diluted earnings per share | -5.63 USD/share | 14.9 USD/share | -9.16 USD/share | -15.03 USD/share | — |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.